Request Sample

Global Polycystic Ovarian Syndrome (PCOS) Treatment Market

Dec. 1, 2019

Global Polycystic Ovarian Syndrome (PCOS) Treatment Market, By Drug Class (Contraceptives & Antiandrogens (Provera, Yasminell, Clomid, Aldactone, Diane 35, and Others), Insulin Sensitizing Agents (Pioglitazone, Rosiglitazone, and Others), Anti-Depressants, Anti-obesity Agents (Xenical, Qsymia, Belviq, and Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR273      
Pages :190 Pages
Format :   PPT Format   PDF Format

The global polycystic ovarian syndrome (PCOS) treatment market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Rising rates of obesity, increasing incidence of diabetes, genetic population, and hormonal disorders/diseases are some of the factors expected to drive the market growth. Additionally, obese and diabetic females are likely to be more prone to this syndrome, which is why demand and requirement for treatment of PCOS is expected to foster globally.

Table 1. Global Polycystic Ovarian Syndrome Treatment Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Drug Class)

Contraceptives & Antiandrogens (Provera, Yasminell, Clomid, Aldactone, Diane 35, and Others), Insulin Sensitizing Agents (Pioglitazone, Rosiglitazone, and Others), Anti-Depressants, Anti-obesity Agents (Xenical, Qsymia, Belviq, and Others)

Market Segmentation (By Distribution Channel)

Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East & Africa,

Key Players Coverage

Bayer AG, Abbott, Merck KGaA, Pfizer, Inc., AstraZeneca, Sanofi, Bristol Myers Squibb Company, Novartis AG, Teva Pharmaceutical Industries Ltd, Ferring B.V, among others

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

Increasing prevalence of hormonal disorders and  sedentary lifestyle is leading to rise in cases of PCOS in women, this is expected to drive the polycystic ovarian syndrome (PCOS) treatment market in the near future. For instance, according to catalyst,org women account for more than 40% of total labor force in many countries. Metabolic dysfunction in PCOS can lead to excess androgen secretion, which can cause insulin secretion and eventually increase diabetes risk. Further rise in significant funding by various government is expected to boost the market growth. In 2017, as part of a multi-year endowment from PCOS Diva, the nonprofit organization, PCOS Challenge, Inc. will be offering grants up to $500 to help women and girls struggling with hair and skin issues related to polycystic ovary syndrome (PCOS). Nevertheless, increase in enormous number of generic and off-label drugs may hinder the growth of the global market.

Figure 1. Polycystic Ovarian Syndrome Treatment Market Scenario Forecast (Likely, Conservative, and Optimistic Scenario), 2019 and 2025 (US$ Mn)

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

North America is expected to lead the polycystic ovarian syndrome treatment market. The increasing incidence of obesity and overweight population leads to an increase in the number of people suffering from PCOS, which is one of the key factors contributing to North American market growth. For instance, according to health data.org an estimated 160 million Americans are either obese or overweight, of which 60 % are women. Europe, is expected to be the second largest market for PCOS treatment. Increasing knowledge about the benefits of regular check-ups is likely to increase in several new cases that are predicted to be diagnosed in this region each year, thus contributing to the expansion of the market.

Asia-Pacific is expected to grow at a fastest growth rate, owing to presence of countries such as China and India. The emergence of a high number of target-patient pool therefore provides substantial growth opportunities for the region's PCOS treatment industry. These countries' governments focus on controlling the growing prevalence of PCOS by conducting programs that support the diagnosis and treatment of this syndrome and the lifestyle modification required. For instance, in 2017, according to Longdom Publishing, National Institute for Research in Reproductive Health (NIRRH) developed model of Multidisciplinary PCOS Clinic, first of its kind in India in a government health research institute.

Figure 2. Regional Analysis

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

Competitve Landscape

Key players in the global polycystic ovarian syndrome treatment market Bayer AG, Abbott, Merck KGaA, Pfizer, Inc., AstraZeneca, Sanofi, Bristol Myers Squibb Company, Novartis AG, Teva Pharmaceutical Industries Ltd, Ferring B.V, among others. The key players in this market are focused on adopting strategies for mergers & acquisitions, collaborations & partnerships so as to strengthen their market hold. For instance, in January 2020, Bayer AG announced a 5 year multi target partnership with Evotec SE to deal with women’s health for PCOS treatment.

Figure 3. Market Share of Key Players, 2019

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

 

By Drug Class

  • Contraceptives & Antiandrogens
    • Provera
    • Yasminell
    • Clomid
    • Aldactone
    • Diane 35
    • Others
  • Insulin Sensitizing Agents
    • Pioglitazone
    • Rosiglitazone
    • Others
  • Anti-Depressants
  • Anti-obesity Agents
    • Xenical
    • Qsymia
    • Belviq
    • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global polycystic ovarian syndrome treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global polycystic ovarian syndrome treatment market?
  • What key factors are expected to increase the demand for polycystic ovarian syndrome treatment market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global polycystic ovarian syndrome treatment market?
  • Which drug class is expected to dominate the polycystic ovarian syndrome treatment market in the coming years?
  • Which distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies) is expected to dominate the polycystic ovarian syndrome treatment market in the coming years?
  • What was the total revenue generated by the global polycystic ovarian syndrome treatment market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global polycystic ovarian syndrome treatment market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the PCOS Treatment market?
  • What new products are going to be approved or launched in the coming years which may have huge impact on the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Oncology Precision Medicine Market

Global Oncology Precision Medicine Market, By Ecosystem (Applied Sciences (Genomics, Pharmacogenomics and Other Applied Sciences), Precision Diagnostics (Molecular Diagnostics …

Read More

Global Small Molecule Drug Discovery Market

Global Small Molecule Drug Discovery Market, By Therapeutic Type (Central Nervous System (CNS), Cardiovascular, Oncology, Metabolic Disorders, Gastrointestinal, Orthopedics, …

Read More

Global Diabetes Drugs Market

Global Diabetes Drugs Market, By Diabetes Type (Type-1 & Type-2), By Drug (Oral Anti-Diabetic Drugs (Biguanides, Alpha-Glucosidase Inhibitors, Dopamine …

Read More

Global Bipolar Disorder Treatment Market

Global Bipolar Disorder Treatment Market, By Drug Type (Antipsychotic, Antidepressant, Anticonvulsants, Antianxiety, Mood Stabilizers, Others), By Bipolar Disorder Type …

Read More

Global Cytotoxic Drugs Contract Manufacturing Market

Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type (Oral, Intravenous), By Form (Liquid, Solid), By Production Scale (Laboratory …

Read More

India Acetazolamide Market

India Acetazolamide Market, By Formulation (Tablets, Capsules, and Injection), By Application (Glaucoma, Epilepsy, Drug-induced Edema, Altitude …

Read More

India Diclofenac Market

India Diclofenac Market, By Indication (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid Arthritis, Migraine, Pain, and Others), By Route of Administration …

Read More

Global Polycystic Ovarian Syndrome (PCOS) Treatment Market

Global Polycystic Ovarian Syndrome (PCOS) Treatment Market, By Drug Class (Contraceptives & Antiandrogens (Provera, Yasminell, Clomid, Aldactone, Diane 35, …

Read More
Validation error occured. Please enter the fields and submit it again.